Longevity biomarker testing market seen reaching $3.99 billion by 2030

The longevity biomarker diagnostic testing market is projected to rise from $1.86 billion in 2025 to $2.17 billion in 2026, driven by personalized healthcare, preventive screening and aging-related disease risk monitoring. The Business Research Company says North America led in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Longevity biomarker testing is moving from niche wellness into a broader diagnostic category tied to preventive care, personalized medicine and aging-related risk detection. - The market’s projected growth signals rising demand for tools that estimate biological age and help clinicians identify disease risk earlier. - The report points to expanding use cases in direct-to-consumer testing, AI-driven analytics and multi-omics profiling.

What happened: - The Business Research Company published its Longevity Biomarker Diagnostic Testing Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on Sept. 18, 2026. - The report values the global market at $1.86 billion in 2025 and projects $2.17 billion in 2026. - The report forecasts the market will reach $3.99 billion by 2030. - The report says the market is growing as interest increases in understanding and managing the aging process. - The report defines longevity biomarker diagnostic testing as laboratory and clinical procedures that measure biological indicators of aging and overall physiological health.

The details: - The market is expected to grow at a 16.9% compound annual growth rate in 2026. - The report forecasts a 16.4% CAGR through 2030. - Growth drivers include rising chronic disease incidence linked to aging, greater preventive healthcare awareness, advances in genetic and molecular diagnostics, broader use of basic biomarker blood tests and stronger clinical laboratory infrastructure. - Future demand is expected to come from personalized and precision medicine, AI-powered diagnostic platforms, wellness and biohacking cultures, direct-to-consumer healthcare testing and multi-omics data in clinical decisions. - Key trends identified in the report include epigenetic age acceleration tracking, AI-driven longevity analytics, direct-to-consumer longevity kits, multi-omics biomarker profiling and more preventive screenings. - Longevity biomarker diagnostics measure genetic, metabolic, proteomic and cellular signals to estimate biological age and the pace of aging. - The testing is positioned as a tool for early identification of age-associated decline and for guiding timely interventions. - North America was the largest regional market in 2025. - Asia-Pacific is forecast to be the fastest-growing region. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The market outlook suggests longevity testing is being pulled by both clinical demand and consumer interest in proactive health tracking. - The combination of AI, multi-omics and direct-to-consumer testing points to a faster shift toward more personalized and data-heavy health screening models. - The report’s emphasis on regional growth shows the market is still concentrated in North America but may broaden quickly as infrastructure and awareness expand in Asia-Pacific. - The report cites the Personalized Medicine Coalition as saying the FDA approved 16 new personalized treatments for rare diseases in 2023, nearly triple the six approvals in 2022.

What's next: - The market will likely be watched for adoption of AI-based longevity tools, broader consumer testing and more integration of biomarker data into routine care. - Growth through 2030 will depend on how quickly laboratories, providers and direct-to-consumer platforms scale access to these tests. - The Business Research Company is offering a free sample and the full report through its website.